[go: up one dir, main page]

NO944749D0 - Nye steroider med pregnanskjelett, farmasöytiske preparater inneholdende disse, og fremgangsmåte for fremtilling av disse - Google Patents

Nye steroider med pregnanskjelett, farmasöytiske preparater inneholdende disse, og fremgangsmåte for fremtilling av disse

Info

Publication number
NO944749D0
NO944749D0 NO944749A NO944749A NO944749D0 NO 944749 D0 NO944749 D0 NO 944749D0 NO 944749 A NO944749 A NO 944749A NO 944749 A NO944749 A NO 944749A NO 944749 D0 NO944749 D0 NO 944749D0
Authority
NO
Norway
Prior art keywords
steroids
skeletal
preparing
methods
pharmaceutical preparations
Prior art date
Application number
NO944749A
Other languages
English (en)
Other versions
NO944749L (no
Inventor
Sandor Maho
Zoltan Tuba
Aniko Gere
Pal Vittay
Bela Kiss
Eva Palosi
Laszlo Szporny
Erzsebet Francsicsne Czinege
Anna Mezei Boorne
Gabor Balogh
Sandor Gorog
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of NO944749D0 publication Critical patent/NO944749D0/no
Publication of NO944749L publication Critical patent/NO944749L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50Three nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NO944749A 1992-06-09 1994-12-08 Nye steroider med pregnanskjelett, farmasöytiske preparater inneholdende disse, og fremgangsmåte for fremtilling av disse NO944749L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9201910A HU212308B (en) 1992-06-09 1992-06-09 Process for producing novel pregnane steroids and pharmaceutical compositions containing the same
PCT/HU1993/000035 WO1993025570A1 (en) 1992-06-09 1993-06-08 Novel steroids with pregnane skeleton, pharmaceutical compositions containing them and process for preparing same

Publications (2)

Publication Number Publication Date
NO944749D0 true NO944749D0 (no) 1994-12-08
NO944749L NO944749L (no) 1995-02-08

Family

ID=10982020

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944749A NO944749L (no) 1992-06-09 1994-12-08 Nye steroider med pregnanskjelett, farmasöytiske preparater inneholdende disse, og fremgangsmåte for fremtilling av disse

Country Status (17)

Country Link
US (1) US5547949A (no)
EP (1) EP0646126A1 (no)
JP (1) JPH07507792A (no)
KR (1) KR950701933A (no)
AU (1) AU4352393A (no)
CA (1) CA2136546A1 (no)
CZ (1) CZ308094A3 (no)
EE (1) EE9400071A (no)
FI (1) FI945781A (no)
HR (1) HRP930956A2 (no)
HU (1) HU212308B (no)
IL (1) IL105943A0 (no)
NO (1) NO944749L (no)
RU (1) RU94046369A (no)
SI (1) SI9300311A (no)
WO (1) WO1993025570A1 (no)
ZA (1) ZA934036B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69942578D1 (de) 1998-05-22 2010-08-26 Univ R Bifunktionelle moleküle sowie darauf basierende therapien.
US20040127502A1 (en) * 2001-01-31 2004-07-01 Synaptic Pharmaceutical Corporation Use of GAL3 antagonist for treatment of depression
US7081470B2 (en) * 2001-01-31 2006-07-25 H. Lundbeck A/S Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
MY141867A (en) * 2002-06-20 2010-07-16 Vertex Pharma Substituted pyrimidines useful as protein kinase inhibitors
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
NL2000323C2 (nl) * 2005-12-20 2007-11-20 Pfizer Ltd Pyrimidine-derivaten.
EP2805720B1 (en) 2008-05-28 2019-08-07 ReveraGen BioPharma, Inc. Non-hormonal steroid modulators of NF-KB for treatment of disease
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
MY163048A (en) 2009-05-06 2017-08-15 Laboratory Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT
WO2017004205A1 (en) 2015-06-29 2017-01-05 Reveragen Biopharma, Inc. NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5099019A (en) * 1985-09-12 1992-03-24 Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
ES2078890T3 (es) * 1986-10-09 1996-01-01 Upjohn Co Amino esteroides en c20 a c26.
FR2644789B1 (fr) * 1989-03-22 1995-02-03 Roussel Uclaf Nouveaux steroides 19-nor, 3-ceto comportant une chaine en 17 aminosubstituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
FR2644787B1 (fr) * 1989-03-22 1995-02-03 Roussel Uclaf Nouveaux steroides 21 aminosubstitues, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
CA2071000A1 (en) * 1990-01-26 1991-07-27 John M. Mccall 5-oxygenated-2,4,6-triaminopyrimidines

Also Published As

Publication number Publication date
KR950701933A (ko) 1995-05-17
SI9300311A (sl) 1993-12-31
HUT64562A (en) 1994-01-28
EE9400071A (et) 1995-12-15
HU9201910D0 (en) 1992-09-28
FI945781A0 (fi) 1994-12-08
ZA934036B (en) 1994-01-06
IL105943A0 (en) 1993-10-20
AU4352393A (en) 1994-01-04
JPH07507792A (ja) 1995-08-31
HU212308B (en) 1996-05-28
EP0646126A1 (en) 1995-04-05
WO1993025570A1 (en) 1993-12-23
HRP930956A2 (hr) 1995-02-28
FI945781A (fi) 1994-12-08
RU94046369A (ru) 1996-09-27
CZ308094A3 (en) 1995-11-15
US5547949A (en) 1996-08-20
CA2136546A1 (en) 1993-12-23
NO944749L (no) 1995-02-08

Similar Documents

Publication Publication Date Title
DK165112C (da) 2,2'-iminobisethanolderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende disse
DK539789D0 (da) Carbostyrilderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant carbostyrilderivat
EP0263569A3 (en) 9-alpha-hydroxysteroids,process for their preparation,process for the preparation of the corresponding 9(11)-dehydro-derivatives and pharmaceutical preparations containing said steroids
DK214090D0 (da) 5-aminosulfonylalkyl-indolderivater, fremgangsmaade og mellemprodukt til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
NO893896D0 (no) Farmasoeytiske formuleringer og fremgangsmaate for fremstilling av disse.
DK162445C (da) Pyranopyridiner, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende pyranopyridinerne
DK211084D0 (da) Hurtigtoploesende laegemiddelpraeparater og fremgangsmaade til fremstilling heraf
NO305316B1 (no) Nye substituerte 1H-imidazoler og farmas°ytiske preparater inneholdende disse
NO304073B1 (no) Nye steroider, farmasöytisk preparat inneholdende disse forbindelsene og deres anvendelse
NO304074B1 (no) Nye steroidestere, farmasöytisk preparat inneholdende disse forbindelsene og deres anvendelse
NO880443D0 (no) N-heterosyklisk-n-(4-piperidyl)amider og farmasoeytiske preparater og fremgangsmaater for bruk av slike forbindelser.
NO944749D0 (no) Nye steroider med pregnanskjelett, farmasöytiske preparater inneholdende disse, og fremgangsmåte for fremtilling av disse
DK0635004T3 (da) 4-Diphenylmethylpiperidinderivater og fremgangsmåde til fremstilling deraf
IL90007A0 (en) N-alkoxy-alkylamido derivatives,methods for the preparation thereof and cosmetic preparations containing the same
DK162892C (da) 1,2,5,6-tetrahydropyridinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse
GR3001097T3 (en) 4-quinolone-3-carboxylic-acid derivatives, process for their synthesis and pharmaceutical preparations containing them
DK114584A (da) Fast farmaceutisk praeparat samt fremgangsmaade til fremstilling deraf
NO930796D0 (no) Glykopeptidderivater, fremgangsmaate for deres fremstilling og farmasoeytiske midler inneholdende disse
DK396385A (da) 2,3-dihydro-lh-indenderivater, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse forbindelser
DK469189D0 (da) Substituerede thienopyraner, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK92789A (da) Polypeptidderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse
LTIP760A (en) Novel thienothiazine derivatives, process for preparing thereof and pharmaceutical preparations
DK251386A (da) 11-betasubstituerede steroider, fremgangsmaade til fremstilling heraf og farmaceutiske og veterinaere praeparater indeholdende disse forbindelser
HUT65224A (en) Process for producing alkoxymethylsubstituted pyridonbiphenyl derivatives and pharmaceutical preparations containing them
DK155692A (da) Benzofuranylimidazolderivater, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende disse